Glycan tools and technologies to study sugars in health and disease
Official title: Protein-Glycan Interaction Resource at the National Center for Functional Glycomics (NCFG)
Funded at Beth Israel Deaconess Medical Center · NIH-11422872 · Data updated 2026-11-12
A renewal project at a major medical center that develops and shares glycan-based technologies to help researchers understand how sugars on proteins and lipids influence health and disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | July 1, 2020 |
| Project end | May 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $778,050 |
| NIH project number | 2R24GM137763-06 |
| Project ID | NIH-11422872 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not applicable for this project as described; the work is technology development and sharing rather than a patient-facing trial.
✕Less likely to help
Direct patient participation is not described; the grant centers on technology development and dissemination.
What this research studies
This project continues the National Center for Functional Glycomics’ work on glycan structures and their interactions with binding proteins and antibodies. It focuses on expanding technologies like glycan microarrays, mass-spectrometry analyses, and glycoconjugate libraries to support broad biological and medical research. Researchers from many fields can access these tools to study how glycosylation affects disease pathways and patient health. The center plans to recruit new users and provide customized resources to accelerate discoveries. It is a facility-focused renewal that aims to enhance collaboration and technology dissemination across the glycoscience community.
Why it matters
Potential benefit: Patients could benefit indirectly through faster discoveries into diseases linked to glycosylation, potentially informing new diagnostics and therapies.
How similar studies have gone: The center has a track record of enabling glycoscience research with impactful technologies, indicating ongoing potential for success with expanded capabilities.
Where this research is happening
-
Beth Israel Deaconess Medical Center
Boston, United States Active
Researchers
- Principal investigator: Cummings, Richard D — Beth Israel Deaconess Medical Center
- Study coordinator: Cummings, Richard D
Related research
Other NIH-funded projects on the same topics.
-
SATURN MRI ancillary study: statins after intracerebral hemorrhage and brain MRI markers
This study looks at what happens to brain MRI markers and health outcomes when people with a specific type of brain bleed continue or stop taking statins.
-
Statin use after brain bleed MRI study in ICH patients (SATURN MRI) Ancillary Study
This project tests whether continuing or stopping statin therapy after an intracerebral hemorrhage affects brain changes seen on MRI and related health outcomes in people with lobar ICH.
-
Statin use after brain bleed: SATURN MRI ancillary study
This project tests whether continuing statin medicines after a brain bleed (lobar intracerebral hemorrhage) affects new brain blood vessel findings and long-term health.
-
XenCAT: Single Cell Atlas for Xenopus
Aims to map gene activity at the single-cell level in Xenopus to help understand how cells develop and how this relates to human disease.
-
Statin use after lobar intracerebral hemorrhage
This trial compares continuing versus stopping statins in people who had a lobar intracerebral hemorrhage to see how that affects repeat brain bleeds, strokes, heart attacks, and recovery over two years.
-
Statin use after lobar brain hemorrhage
This trial compares stopping versus continuing statin medicine in people who had a lobar brain bleed to learn effects on repeat bleeding and future heart or stroke events.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.